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Abstract
Background: Sepsis has represented a substantial health care and economic burden worldwide during the previous
several decades. Our aim was to analyze the epidemiological trends of hospital admissions, deaths, hospital resource
expenditures, and associated costs related to sepsis during the twenty-first century in Spain.
Methods: We performed a retrospective study of all sepsis-related hospitalizations in Spanish public hospitals from
2000 to 2013. Data were obtained from records in the Minimum Basic Data Set. The outcome variables were sepsis,
death, length of hospital stay (LOHS), and sepsis-associated costs. The study period was divided into three calendar
periods (2000–2004, 2005–2009, and 2010–2013).
Results: Overall, 2,646,445 patients with sepsis were included, 485,685 of whom had died (18.4%). The incidence
of sepsis (events per 1000 population) increased from 3.30 (2000–2004) to 4.28 (2005–2009) to 4.45 (2010–2013)
(p < 0.001). The mortality rates from sepsis (deaths per 10,000 population) increased from 6.34 (2000–2004) to 7.88
(2005–2009) to 7.89 (2010–2013) (p < 0.001). The case fatality rate (CFR) or proportion of patients with sepsis who
died decreased from 19.1% (2000–2004) to 18.4% (2005–2009) to 17.9% (2010–2013) (p < 0.001). The LOHS (days)
decreased from 15.9 (2000–2004) to 15.7 (2005–2009) to 14.5 (2010–2013) (p < 0.001). Total and per patient
hospital costs increased from 2000 to 2011, and then decreased by the impact of the economic crisis.
Conclusions: Sepsis has caused an increasing burden in terms of hospital admission, deaths, and costs in the Spanish
public health system during the twenty-first century, but the incidence and mortality seemed to stabilize in 2010–2013.
Moreover, there was a significant decrease in LOHS in 2010–2013 and a decline in hospital costs after 2011.
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Background
Sepsis is a life-threatening dysfunction of the organs
caused by a dysregulated host response to infection. It is
the primary cause of death from infection, especially if it
is not recognized and treated promptly [1]. Sepsis has
represented a substantial health care and economic
burden worldwide during the last decades for several
reasons [2, 3]. Firstly, sepsis affects millions of people
around the world each year and is the main cause of
death among critically ill patients [4–6]. The incidence
of sepsis varies across the world. The incidence of severe
sepsis has been estimated at around 300 cases per
100,000 population in the United States, and half of
these patients are treated in the intensive care unit
(ICU) [4]. The incidence of severe sepsis in Sweden in
2005 was 430 per 100,000 population [7]. Additionally,
in clinical cohort studies in ICUs, the incidence of sepsis
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is 11.8% in Australia and New Zealand [8], 14.6% in
France [9], 27.1% in the United Kingdom [10], and 30%
in the SOAP study [5], which included 198 European
ICUs. In most developed countries, sepsis has progres-
sively increased during the last decades [6]. Secondly,
patients with sepsis tend to require high resource
expenditure in the hospital and the costs of sepsis are
quite substantial [2, 3]. The estimated cost per episode
in the US is between $20,000 and $50,000; however, the
level of cost is related to age, severity of illness, intensive
care unit admission, and number of unscheduled surgi-
cal procedures, among others [4, 11–14]. The total
sepsis-related cost in the US has been estimated at $16
to $25 billion annually [4, 11]. However, there is growing
evidence on the impact of the economic crisis on
hospital care utilization after 2008 [15–17], but there is
little information about the impact of the economic cri-
sis on critical care utilization.
The rise in sepsis rates has promoted national and
global efforts to improve awareness, early recognition,
diagnosis, and management [18]. The Surviving Sepsis
Campaign was developed in 2004 to promote guidelines
and performance-improvement practices with the objective
of reducing deaths from sepsis worldwide [19]. This has
meant that despite the increase in sepsis incidence, the
case fatality rate (CFR) has significantly decreased in most
developed countries [2, 20–24]. However, the CFR remains
higher than for heart failure and other important patholo-
gies such as breast cancer, colon cancer, and AIDS [25].
Despite these data, there is limited information on the
epidemiology of sepsis in Europe in the twenty-first
century [7, 24, 26].
The aim of this study was to analyze the epidemio-
logical trends of hospital admissions, deaths, hospital
resource expenditures, and associated costs related to
sepsis from 2000 to 2013 in Spain.
Methods
Study design and data source
We carried out a nationwide population-based retro-
spective study of all hospitalizations involving sepsis in
Spanish public hospitals between January 1, 2000 and
December 31, 2013.
Data were obtained from records in the Minimum
Basic Data Set (MBDS) of the National Surveillance
System for Hospital Data in Spain, provided by the
Ministry of Health Social Services and Equality (MSSSI).
The MBDS is a clinical and administrative database
containing clinical information recorded at the time of
hospital discharge, which has an estimated coverage of
92% of hospital discharges registered in hospitals in Spain
(84.14% from public hospitals and 15.86% from private
hospitals) [27]. The MBDS includes up to 14 discharge
diagnoses and up to 20 procedures performed during the
hospital stay. The MBDS provides encrypted patient iden-
tification numbers (the identification of individual patients
is not possible in the MBDS), gender, date of birth, dates
of hospital admission and discharge, medical institutions
providing the services, the diagnosis and procedure codes
according to the International Classification of Diseases
9th Revision, Clinical Modification (ICD-9-CM), as well as
the outcome at discharge [28]. The Spanish MSSSI sets
standards for record-keeping and performs periodic audits
on the MBDS.
The data were treated with full confidentiality according
to Spanish legislation. The MBDS is regulated by law
explaining how institutions are required to utilize health-
related personal data. The MSSSI of Spain confirmed that
our study fulfilled all ethical considerations according to
Spanish legislation. Thus, given the anonymous and
mandatory nature of the data, informed consent was not re-
quired or necessary.
Study variables
Sepsis was defined as the presence of an infection-
associated diagnosis and organ dysfunction according to
the criteria of Angus et al. [4] and adapted by other
authors. We selected all acute-care hospitalizations with
ICD-9-CM codes for both bacterial or fungal infections
(ICD-9-CM codes used by Angus et al. [4]; see
Additional file 1: Table S1) and a diagnosis of acute
organ dysfunction (ICD-9-CM codes used by Angus et
al. [4], Dombrovskiy et al. [20], and Shen et al. [29]; see
Additional file 1: Table S2).
The main study factor was time, which was divided
into calendar years and into three calendar periods
(2000–2004, 2005–2009, and 2010–2013) related to
protocols from the Surviving Sepsis Campaign (http://
www.survivingsepsis.org/). The first guideline of the
Surviving Sepsis Campaign was published in 2004 [19]
with the stated goal of reducing mortality from sepsis by
25% in five years.
The main outcomes were the onset of sepsis (hospital
admission with infection plus organ dysfunction) and
death in patients with sepsis. The minor outcomes were
the length of hospital stay (LOHS) and the costs related
to sepsis.
Statistical analyses
The percentage of sepsis was estimated as the propor-
tion of hospital admissions that were diagnosed cases
of sepsis. The percentage of in-hospital sepsis-related
deaths was defined as the proportion of overall in-
hospital deaths that were of septic patients. The CFR
was estimated as the proportion of hospitalized patients
with sepsis that died. The incidence of sepsis was
defined as number of events per 1000 persons in the
population. The mortality of sepsis was defined as
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number of deaths per 10,000 persons in the population.
The incidence and mortality were standardized by age
by direct method using as population reference the
whole population in Spain (National Statistics Institute;
http://www.ine.es/). Thus, the number of events was
used as numerator and the denominator was the
number of persons at risk by age group. We also
calculated the odds for in-hospital sepsis-related death
according to calendar period by using logistic regres-
sion models, which were adjusted by age, sex, and
Charlson co-morbidity index (CCI; see Additional file 1:
Table S4) [30].
The LOHS was obtained as the difference in days
between the date of hospital admission and date of
discharge or death. The day of hospital admission was
considered to be day 0. Discharge on the same day was
considered to be a one day stay. Costs were calculated
using Diagnosis-Related Groups (DRG), which repre-
sents a medical-economic entity concerning a set of
diseases requiring analogous management resources
[27]. DRG data were extracted from the MBDS. All costs
shown are adjusted for the increment of inflation for the
same period in Spain.
Temporal trends by calendar periods were evaluated
using Poisson distribution or ANOVA as appropriate.
All analyses were performed using the R statistical
package, version 3.2.2 (GNU General Public License)




Table 1 shows the epidemiological and clinical character-
istics of patients with sepsis. On the whole, 2,646,445 pa-
tients had sepsis from 2000 to 2013 in Spain (Table 1A),
of whom 485,685 died (18.4%) (Table 1B). Most of the
patients were men with medical conditions and CCI
above 2. The organs most commonly affected were of
the respiratory and renal systems. The percentages that
were men, and that had dysfunction and infection of the
respiratory system decreased significantly from 2000–
2004 to 2010–2013 (p < 0.001), while the age, CCI, dys-
function and infection of the renal system, and number
and percentage of acute organ dysfunction increased sig-
nificantly from 2000–2004 to 2010–2013 (p < 0.001)
(Table 1 A & B).
Frequency of sepsis and sepsis-related death
The percentage of hospital admissions due to sepsis
increased from 3.6% in 2000 to 5.8% in 2013 (Fig. 1).
The percentage of in-hospital sepsis-related deaths also
increased, from 18.7% in 2000 to 29% in 2013 (Fig. 1).
Sepsis-related rates
The incidence of sepsis (events per 1000 population)
increased from 2.9 in 2000 to 4.8 in 2013 (p < 0.001)
(Fig. 2a). When the follow-up was stratified by calendar
periods, a significant upward trend was observed from
3.30 (2000–2004) to 4.28 (2005–2009) to 4.45 (2010–
2013) (p < 0.001). Mortality due to sepsis (deaths per
10,000 population) increased from 5.6 in 2000 to 8.3 in
2013 (p < 0.001) (Fig. 2b). When stratified by calendar
periods, a significant upward trend was observed from
6.34 (2000–2004) to 7.88 (2005–2009) to 7.89 (2010–
2013) (p < 0.001). Moreover, the CFR (proportion of
patients with sepsis who died) decreased from 19.0% in
2000 to 17.5% in 2013 (p < 0.001) (Fig. 2c). When strati-
fied by calendar periods, a significant downward trend in
CFR was observed from 19.1% (2000–2004) to 18.4%
(2005–2009) to 17.9% (2010–2013) (p < 0.001). Additionally,
the likelihood of death when compared to 2000–2003
decreased in 2004–2009 [adjusted odds ratio (aOR) of 0.90
(95% confidence interval (95% CI): 0.89, 0.91)] and 2010–
2013 [aOR= 0.81 (95% CI: 0.80, 0.82)].
National age-specific rates
The incidence and mortality of sepsis increased in late
adulthood (aged 50–59 years), increased sharply in the
elderly (aged > 65 years), and reach the highest values in
the elderly over 85 (Fig. 3a–b). The trends in incidence
and mortality were different according to calendar
periods after age 65 with the highest values, although
quite similar, in 2005–2009 and 2010–2013 (Fig. 3a–b).
Moreover, the CFR increased from 7.2% in children to
values above 20% in patients aged 45–49 years, but a
break in the upward trend was found between ages 45–
49 years and 60–64 years, since the values decreased or
remained constant. Above age 65, the CFR increased
quickly to values close to 30% by age 85 (Fig. 3c). The
lowest values were found in 2005–2009 and 2010–2013
for all age groups, with very similar values (Fig. 3c).
Hospital resource expenditure related to sepsis
The average LOHS was 15.3 days during the whole study
period. The LOS values were lower in survivors than in
non-survivors (15.1 vs. 16.4; p < 0.001), in medical condi-
tion than in surgical condition (12.2 vs. 37.9; p < 0.001),
and in patients with organ dysfunction < 2 than in patients
with organ dysfunction ≥2 (14.0 vs. 21.1; p < 0.001).
Furthermore, the LOHS decreased from 15.7 in 2000 to 14.0
in 2013, particularly after 2008 (Fig. 4a). When the follow-up
was stratified by calendar periods, a significant downward
trend in LOHS was observed from 15.9 (2000–2004) to 15.7
(2005–2009) to 14.5 (2010–2013) (p < 0.001).
The average hospital cost per patient was 9090€ during
whole study period. The average cost was lower in survi-
vors than in non-survivors (8423€ vs. 10,219€; p < 0.001), in
Álvaro-Meca et al. Population Health Metrics  (2018) 16:4 Page 3 of 11
Table 1 Epidemiological and clinical characteristics of patients with sepsis in Spain from 2000 to 2013
Entire period 2000–2004 2005–2009 2010–2013
A) Patients with sepsis
No. of patients 2,646,445 686,062 984,207 976,176
Gender (male) 1,695,167 (64.1%) 458,453 (66.82%) 637,428 (64.77%) 599,286 (61.39%)
Age (years) 69.7 (20.0) 68.2 (19.8) 69.4 (20.1) 71 (20)
Medical condition (vs. Surgical condition) 2,312,446 (87.4%) 600,138 (87.48%) 860,081 (87.39%) 852,227 (87.3%)
Charlson index 2.38 (2.15) 2.1 (2) 2.4 (2.1) 2.6 (2.3)
Number of acute organ dysfunction
Average 1.3 (0.6) 1.2 (0.5) 1.2 (0.6) 1.3 (0.7)
1 Acute organ dysfunction 2,137,412 (80.76%) 587,681 (85.66%) 802,906 (81.58%) 746,555 (76.48%)
2 Acute organ dysfunction 378,431 (14.30%) 76,217 (11.11%) 135,002 (13.72%) 167,212 (17.13%)
> 2 Acute organ dysfunction 130,872 (4.95%) 22,164 (3.23%) 46,299 (4.7%) 62,409 (6.39%)
Acute organ dysfunction
Cardiovascular 270,390 (10.2%) 59,983 (8.74%) 99,886 (10.15%) 110,521 (11.32%)
Hematologic 138,943 (5.3%) 27,850 (4.06%) 48,487 (4.93%) 62,606 (6.41%)
Hepatic 79,577 (3%) 20,643 (3.01%) 30,405 (3.09%) 28,529 (2.92%)
Metabolic 143,684 (5.4%) 24,273 (3.54%) 50,643 (5.15%) 68,768 (7.04%)
Neurologic 113,885 (4.3%) 31,578 (4.6%) 40,561 (4.12%) 41,746 (4.28%)
Renal 658,149 (24.9%) 127,662 (18.61%) 221,451 (22.5%) 309,036 (31.66%)
Respiratory 1,926,562 (72.8%) 520,799 (75.91%) 735,912 (74.77%) 669,851 (68.62%)
Site of infection
Central nervous system 19,342 (0.7%) 5716 (0.83%) 7387 (0.75%) 6239 (0.64%)
Circulatory 11,560 (0.4%) 2812 (0.41%) 4229 (0.43%) 4519 (0.46%)
Digestive 238,578 (9%) 59,591 (8.69%) 86,877 (8.83%) 92,110 (9.44%)
Genitourinary 506,124 (19.1%) 102,125 (14.89%) 175,486 (17.83%) 228,513 (23.41%)
Respiratory 1,583,486 (59.8%) 469,245 (68.4%) 594,592 (60.41%) 519,649 (53.23%)
B) Sepsis-related deaths
No. of patients 485,685 130,927 181,008 173,750
Gender (male) 297,245 (61.2%) 82,713 (63.17%) 111,552 (61.63%) 102,980 (59.27%)
Age (years) 74.19 (15.95) 72.1 (16.6) 74 (16.1) 75.9 (15.1)
Medical condition (vs. Surgical condition) 381,972 (78.6%) 100,069 (76.43%) 141,779 (78.33%) 140,124 (80.65%)
Charlson index 2.92 (2.57) 2.6 (2.4) 2.9 (2.6) 3.1 (2.7)
Number of acute organ dysfunction
Average 1.64 (0.91) 1.5 (0.8) 1.6 (0.9) 1.7 (1)
1 Acute organ dysfunction 283,418 (58.4%) 83,968 (64.13%) 106,277 (58.71%) 93,173 (53.62%)
2 Acute organ dysfunction 125,631 (25.9%) 31,803 (24.29%) 46,427 (25.65%) 47,401 (27.28%)
> 2 Acute organ dysfunction 76,636 (15.8%) 15,156 (11.58%) 28,304 (15.64%) 33,176 (19.09%)
Acute organ dysfunction
Cardiovascular 135,996 (28%) 35,533 (27.14%) 50,943 (28.14%) 49,520 (28.5%)
Hematologic 36,600 (7.5%) 8115 (6.2%) 13,189 (7.29%) 15,296 (8.8%)
Hepatic 27,507 (5.7%) 6148 (4.7%) 10,676 (5.9%) 10,683 (6.15%)
Metabolic 39,646 (8.2%) 6827 (5.21%) 14,196 (7.84%) 18,623 (10.72%)
Neurologic 26,414 (5.4%) 7104 (5.43%) 9528 (5.26%) 9782 (5.63%)
Renal 179,575 (37%) 39,769 (30.37%) 64,127 (35.43%) 75,679 (43.56%)
Respiratory 350,234 (72.1%) 94,372 (72.08%) 132,677 (73.3%) 123,185 (70.9%)
Álvaro-Meca et al. Population Health Metrics  (2018) 16:4 Page 4 of 11
medical condition than in surgical condition (5334€ vs.
32,854€; p < 0.001), and in patients with organ dysfunction
< 2 than in patients with organ dysfunction ≥2 (7307€ vs.
15,120€; p < 0.001). Furthermore, the average hospital cost
per patient increased from 5533€ in 2000 to above 10,000€
after 2010, but then decreased after 2011 (Fig. 4b). When
stratified by calendar periods, a significant upward trend in
average cost was observed from 6991€ (2000–2004) to
9096€ (2005–2009) to 10,029€ (2010–2013) (p < 0.001).
Moreover, the total national annual cost of hospitalization
due to sepsis increased from 652 M euros in 2000 to over
2500 M after 2010, but with a decrease after 2011 (Fig. 4c).
National age-specific hospital resource expenditure related
to sepsis
The LOHS was high in infants and children under age 5
(LOHS 21.8), decreased quickly in slightly older children
(age 5–9 years; LOHS 13.2), increased sharply for
patients in early adulthood (age 20–24 yrs.; LOHS 25.3),
and decreased sharply for the elderly (age 85 years;
LOHS 11.1) (Fig. 5a). The lowest LOHS values were
found in 2010–2013, with a clear decrease in LOHS for
patients between age 15 and 54 (Fig. 5a).
The average hospital cost per patient was high in
infants and children under age 5, decreased quickly in
children age 5–9 years, increased sharply for patients in
early adulthood (age 20–24 years), and decreased sharply
for the elderly over 85 (Fig. 5b). By calendar periods,
2005–2009 marked a significant increase in spending,
which was surpassed in 2010–2013 for patients between
age 24 and 79 (Fig. 5b).
The total national cost was high in infants and
children under 5, decreased quickly in children age 5–
9 years, increased gradually until elderly patients age
Table 1 Epidemiological and clinical characteristics of patients with sepsis in Spain from 2000 to 2013 (Continued)
Entire period 2000–2004 2005–2009 2010–2013
Site of infection
Central nervous system 4809 (1%) 1580 (1.21%) 1814 (1%) 1415 (0.81%)
Circulatory 4376 (0.9%) 1120 (0.86%) 1608 (0.89%) 1648 (0.95%)
Digestive 67,565 (13.9%) 18,937 (14.46%) 25,380 (14.02%) 23,248 (13.38%)
Genitourinary 91,702 (18.9%) 19,976 (15.26%) 33,065 (18.27%) 38,661 (22.25%)
Respiratory 252,718 (52%) 75,801 (57.9%) 95,289 (52.64%) 81,628 (46.98%)
Values are expressed as absolute number (percentage) and mean (standard deviation)
Fig. 1 Trends of percentage of patients with sepsis and percentage of sepsis-related deaths among all hospital admissions and deaths
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70–79 years, and decreased sharply in the elderly over
80 (Fig. 5c). By calendar periods, the highest values were
found in the last two calendar periods (2005–2009 and
2010–2013), especially in patients over 50 during the
period 2010–2013 (Fig. 5c).
Regional differences of sepsis epidemiology in Spain
Values of sepsis incidence and sepsis-related mortality were
not uniform throughout the various regions (autonomous
communities) of Spain (p < 0.001; Table 2). When the
follow-up was stratified by calendar periods (Table 2),
values of sepsis incidence increased significantly in all
regions except Cantabria, and values of mortality increased
significantly in all regions except Cantabria, Ceuta, and La
Rioja (Table 2).
Discussion
Our research shows the growing burden of sepsis during
the early twenty-first century in Spain. In this study, the
percentage of sepsis cases and in-hospital sepsis-related
deaths, with respect to overall hospital admissions and
deaths, increased from 2000 to 2013. The adjusted rates
of incidence and mortality also increased, and although
their values were not uniform across regions in Spain,
these rate values increased significantly in most regions
when the follow-up was stratified by calendar periods.
Prior studies have also demonstrated this trend, regard-
less of the algorithm used to determine the diagnosis of
sepsis from the ICD-9 codes [4, 11, 20, 21, 24, 29].
Additionally, in our findings, sepsis and sepsis-related
deaths occurred more frequently in older people, who
also had more comorbidity and developed a higher rate
of acute organ failure, likely due to the natural process
of aging and an accompanying increase in disease
severity. These trends may be due to the increasing age
of the Spanish population, greater comorbidity, greater
use of invasive procedures and immunosuppressive
drugs, and nosocomial infections generally associated
with resistant microorganisms [2, 6]. However, we
should not exclude a possible bias due to a greater
Fig. 2 Trends of sepsis incidence, sepsis-related mortality, and case fatality rate in Spain from 2000 to 2013. a Population-adjusted incidence of
sepsis; b Population-adjusted mortality related to sepsis; c Case fatality rate or proportion of deaths among patients hospitalized with sepsis
Fig. 3 National age-specific rates (incidence, mortality, and case fatality rate) for sepsis in Spain (2000–2013) stratified by calendar periods. a incidence;
b sepsis-related mortality; c case fatality rate or proportion of deaths among patients hospitalized with sepsis
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awareness of the severity of sepsis [18]. Furthermore, the
introduction and improvement of the management of
ICD-9 codes may have facilitated coding in medical
records similar to MBDS [7]. Namely, as awareness of
sepsis has increased during the last decade, the coding
practices might have been become more inclusive [32].
Thereby, if an increasing number of less sick patients
were included as patients with sepsis, the incidence of
sepsis could have increased. However, we have not been
able to evaluate this hypothesis via the MBDS and we do
not have access to severity of illness scores such as
SOFA or APACHE for adjusting the analysis.
We found that the CFR of sepsis decreased during the
14-year study period, consistent with the overall decreasing
trend observed in prior studies [33]. Although small in
percentage, the decline in CFR may be considered remark-
able given the increases in age, morbidity, and severity of
illness. In addition to the above-mentioned comments, this
downward trend may also be attributable to general
improvements in intensive care and the Surviving Sepsis
Campaign [19] that have resulted in an increased aware-
ness of sepsis over time. However, we should not exclude
possible bias due to a greater awareness of the severity of
sepsis [18], as mentioned above. As with other metrics, if
an increasing number of less sick patients were diagnosed
with sepsis, the CFR could decrease.
Overall, the variations in incidence, mortality, and
CFR in our study seem to be lower in comparison to
prior studies [4, 11, 20, 21, 24, 29, 33]. In addition, inci-
dence, mortality, and CFR changes are diminished in the
last calendar period (2010–2013), which could indicate
that they are reaching a plateau. In fact, regardless of
statistical significance, the differences between the last
two calendar periods (2004–2009 vs. 2010–2013) are
very low and virtually nonexistent. This slowdown was
also observed when incidence, mortality, and CFR were
analyzed by age strata. The highest values were found in
elderly over 65, especially in patients over 85, but these
rates were quite similar between 2005 and 2009 and
2010–2013 within each age group.
Fig. 4 Evolution of cost and length of hospital stay for patients with sepsis in Spain from 2000 to 2013. a Average length of hospital stay (LOHS)
per patient; b average cost per patient; c average total cost
Fig. 5 Age-specific hospital resource expenditure in Spain from 2000 to 2013 stratified by calendar periods. a average length of hospital stay
(LOHS) per patient; b average cost per patient; c average total cost
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The average LOHS per calendar year or period is use-
ful from the point of view of costs. The reduction in
LOHS implies a faster recovery and a reduction of costs
and hospital resources. However, patients may also be
discharged with high degrees of disability, and perhaps,
not even going home but to a nursing facility. Previous
studies have showed values of LOHS between 17 and
30 days before 2000, and 9–15 days after 2000 [4, 11, 21,
22, 34]. In our study, LOHS values were close to 16 days
during the first years of the century, but following 2008
decreased to about 14 by 2013. The LOHS trend was
not consistent with the trend of CFR during the study
period, since the LOHS values showed a flat trend in the
first two calendar periods (2000–2004 and 2005–2009)
and decreased in 2010–2013; whereas the CFR values
showed a smooth downward trend during the entire
study period (2000–2013). In addition, the trend of
LOHS was also not consistent with the increase of
hospital costs (per patient and total). However, we must
also highlight that the decreasing trend in LOHS is
particularly important in the context of higher age,
comorbidities, and organ failures in patients. This
decrease in costs that is observed after 2011 could be
due to the economic crisis [15–17], but nor should we
rule out the impact of other factors such as greater
adherence to treatment guidelines [25]. For example,
educational clinical initiatives promoting best practices
in the management of sepsis have been developed in
recent years in Spain [25].
When analysis by age strata was carried out, the highest
values of LOHS and hospital cost per patient were found
in children (< 5 years), teenagers (15–19 years) and adults
(aged 20–59 years). Thus, the trends of LOHS and
hospital cost per patient were quite similar, and patients
with higher LOHS accounted for more hospital spending.
On aggregate, the highest values of total national cost
were found in elderly patients (aged 70–79 years), because
they were the most numerous sepsis patients. It is also
important to note that the impact of calendar periods on
values of LOHS was only evident in the last period (2010–
2013), mainly in patients ranging from 15 to 35 years in
age, since the first two periods had very similar values;
while the hospital costs (per patient and total) reached a
substantial increase in 2005–2009, and was even higher in
2010–2013.
One of the strengths of this study is that it analyzed
nationwide data. Our study captures acute-care hospi-
talizations for sepsis in Spain via MBDS and ICD-9
codes, which is well-established in sepsis epidemi-
ology for assessing its trends and the need for pre-
ventive and therapeutic care and for service planning
[22, 33]. Our study was performed according to a
similar criterion as what was used by Angus et al. [4],
and was only modified to update the codes of acute
organ dysfunction with ICD-9-CM codes used by Dom-
brovskiy et al. [20] and Shen et al. [29]. The Angus criteria
[4] is one of the most well-known and highly cited imple-
mentations of an ICD-coded case definition for sepsis
[35]. Indeed, it is important to also note that the criteria
of Angus et al. [4] coincides with the current definition of
sepsis [1]. In our study, our figures are similar to data re-
ported in other articles that utilize the “Angus” algorithm
[4, 29, 33]. A recent study has compared the “Angus” algo-
rithm to the “Martin” algorithm [36], which selected sepsis
cases based on the presence of an ICD-9-CM code for in-
fection and acute organ dysfunction. The “Angus”
approach has a moderate to low sensitivity of 50.3% and a
positive predictive value of 70.7%, whereas the “Martin”
algorithm has a very low sensitivity of 16.8% but a high
positive predictive value of 97.6% [36]. Thus, the “Angus”
algorithm may capture more sepsis cases than the
“Martin” algorithm, and even so, it is still underestimating
the number of cases [36]. Additionally, the mortality
trends identified using administrative data seem to be
similar to those identified in clinical trial participants, and
support the use of ICD-9 data, integrated into the “Angus”
algorithm, to monitor mortality trends in patients with
sepsis [33].
We should note the existence of a paper on a very
similar topic using the same dataset and another similar
criterion of Angus et al. [24]. Incidence and mortality
rate values in our article were higher than in the Bouza
et al. article, whereas CFR values were higher in their
article [24]. However, the trend of incidence, mortality,
and CFR were similar in both studies. Moreover, our
analysis covers a broader period of time (2000–2013),
which includes the years in which the impact of the
economic crisis was stronger, as well as an analysis of
hospital resource expenditures and associated costs
related to sepsis. These two details result in different
findings and conclusions than those described in the
Bouza’s article [24].
We must also acknowledge other possible limitations
of our study. Firstly, this study was retrospective using
administrative databases, and thus, the acquisition of
some clinical data (community acquired or nosocomial
nature of sepsis, or prognostic scores such as
Child-Pugh, MELD, SOFA, or CLIF-SOFA) was unavail-
able from the MBDS records. Furthermore, we do not
know the reason for admission of these patients and if
these patients were admitted due to sepsis or acquired
sepsis in the hospital prior to death. Secondly, due to
the use of the administrative databases, the inaccuracy
in differentiating the etiology of the diseases and the
reporting of organ dysfunction could have caused a
confusion bias. For example, we found an unexpected
high incidence of urinary infection and low incidence of
cardiovascular dysfunction, possibly due to a bias in
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diagnosis reporting due to the fact that it may be more
reliable to report urinary infection than cardiovascular
dysfunction versus other sources. In this context,
grouping of ICD-9-CM codes into comorbidities, organ
dysfunction, and site of infection (Additional file 1:
Tables S1-S4) may have been the best approach to solve
this issue, considering that we have not used the ICD-9
code 995.9× (sepsis or severe sepsis) nor 785.52 (septic
shock) due to these codes being highly problematic.
Furthermore, we did not have data of the potential
accuracy of the Spanish MBDS for sepsis-related diagno-
ses, which could be a significant limitation. Thirdly,
MBDS data are anonymous, and it is impossible to iden-
tify whether a patient has been hospitalized more than
once in different hospitals. This may have caused a slight
overestimation of incidence and mortality rates since
around one-third of the patients surviving their first
episode of sepsis may develop other subsequent episodes
[29]. Fourthly, the DRG system was the only viable
method to calculate sepsis costs via the MBDS. DRGs
may not be a precise method for determining costs, par-
ticularly in ICU patients, because different conditions in
a DRG may have widely varying costs and different levels
of intensity of care cannot (without adjustment) be
distinguished within a DRG. However, the DRG system
is readily available and provides a uniform methodology
to get a common currency of hospital activity, which
might be applied to all hospitals of a National Health
System. Fifthly, in regard to the referral population, the
population in Spain may vary as to the number of for-
eign habitants that may develop sepsis and be treated in
a public hospital. Besides, private hospitals may also at-
tend a larger proportion of septic patients. However, we
did not have data of these two variables and they could
not be considered for the analysis.
Conclusions
Our data show that sepsis has been an increasing burden
(hospital admission, deaths, and costs) in the Spanish
public health system during the early twenty-first cen-
tury (2000–2013), but incidence and mortality seem to
have stabilized in the last calendar period (2010–2013).
Moreover, there was also a significant decrease in LOHS
values in 2010–2013, accompanied by a decrease in the
hospital costs per patient and total national costs for
sepsis after 2011. These conclusions would benefit from
further attempts to corroborate these findings.
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